Capital Com MENA Securities Trading LLC is regulated by the Capital Market Authority.
Open platformOpen platform

Grail Publishes PATHFINDER 2 Presentation on Diagnostic Workups After Positive Cancer Screening Tests

By Public Technologies
  • Grail published a PATHFINDER 2 research presentation on diagnostic evaluations following positive multi-cancer early detection tests.
  • Cancer signal origin-guided evaluations identified 88% of cancers; the top two origin predictions were accurate in 91% of cases.
  • Diagnostic resolution reached 94.8% among 290 evaluated participants, with a median time of 48 days.
  • Invasive procedures occurred in 91% of participants diagnosed with cancer versus 49.6% of those without cancer at 12 months.
  • PET-CT following negative targeted evaluations found seven additional cancers among 65 participants.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief on October 26, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.